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Cellular memory of hypoxia elicits neuroblastoma metastasis
and enables invasion by non-aggressive neighbouring cells
A Herrmann1,2, M Rice1,3, R Lévy1, BL Pizer3, PD Losty3,4, D Moss2 and V Sée1
Therapies targeting cancer metastasis are challenging owing to the complexity of the metastatic process and the high number of
effectors involved. Although tumour hypoxia has previously been associated with increased aggressiveness as well as resistance to
radio- and chemotherapy, the understanding of a direct link between the level and duration of hypoxia and the individual steps
involved in metastasis is still missing. Using live imaging in a chick embryo model, we have demonstrated that the exposure of
neuroblastoma cells to 1% oxygen for 3 days was capable of (1) enabling cell migration towards blood vessels, (2) slowing down
their velocity within blood vessels to facilitate extravasation and (3) promoting cell proliferation in primary and secondary sites. We
have shown that cells do not have to be hypoxic anymore to exhibit these acquired capabilities as a long-term memory of prior
hypoxic exposure is kept. Furthermore, non-hypoxic cells can be inﬂuenced by neighbouring hypoxic preconditioned cells and be
entrained in the metastatic progression. The acquired aggressive phenotype relies on hypoxia-inducible factor (HIF)-dependent
transcription of a number of genes involved in metastasis and can be impaired by HIF inhibition. Altogether, our results
demonstrate the need to consider both temporal and spatial tumour heterogeneity because cells can 'remember' an earlier
environment and share their acquired phenotype with their close neighbours. As a consequence, it is necessary to monitor the
correct hypoxic markers to be able to predict the consequences of the cells’ history on their behaviour and their potential response
to therapies.
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INTRODUCTION
During tumour progression, cells can become invasive and
colonise distant organs.1 This phenomenon called metastasis is a
critical problem contributing to more than 90% of cancer deaths2
and involves several steps from the initial detachment from the
primary site, diffusion within the surrounding tissue, intravasation
into the blood stream to extravasation and proliferation in the
metastatic site to form secondary tumours.
Increased tumour progression and metastasis have previously
been associated with poorly oxygenated (hypoxic) regions in
primary tumours.3–5 Neuroblastoma (NB), a highly malignant
paediatric solid tumour developing from neural-crest-derived cells
during foetal or early postnatal life, is one example in which a
hypoxic signature is associated with dismal patient outcome.6
Hypoxia is known to trigger dedifferentiation of NB cells towards a
more immature stem cell phenotype and is associated with NB
metastasis.7 More than 60% of NB tumours are metastatic and
secondary tumours can be found in bone, bone marrow, liver,
lymph nodes or, less commonly, in the skin, lung or brain.8
As the oxygen levels found in solid tumours are dynamic, with
cycles of hypoxia and reoxygenation9 and heterogeneous within
the tumour,10,11 it is not trivial to demonstrate a direct link
between oxygen levels and the molecular mechanisms associated
with metastasis. For example, it is unknown which level and
duration of hypoxic exposure is necessary to induce long-lasting
changes in cancer cells leading to the emergence of an aggressive
and metastatic phenotype. To visualise directly the effects of
hypoxic preconditioning from primary tumour invasion into blood
vessels to secondary tumour formation in distant organs sites, we
have used a chick embryo model combined with live in vivo and
ex vivo imaging.
Initially shown to support murine sarcoma xenografts, the chick
embryo has been exploited for more than 100 years.12 The
chorioallantoic membrane (CAM) is a well-vascularised extraem-
bryonic tissue located underneath the eggshell and constitutes an
excellent biological platform for the molecular analysis of cancer
including xenografting, angiogenesis and metastasis.13 As the
chick embryo is naturally immunodeﬁcient in the early stages of
development,14 the CAM readily supports the engraftment of
tumour tissues.
We have shown here that NB cells can be successfully grown
as a tumour on the CAM, without spontaneous dissemination.
We further demonstrate that hypoxic preconditioning modiﬁes
the cells’ phenotype, leading to metastasis into the chick organs.
We report that hypoxic preconditioning affects cell adhesion
in opposing ways depending on the metastatic stage and triggers
durable changes in gene expression in vivo. Importantly, we
have observed that cells preexposed to a hypoxic environment
can trigger metastasis of non-hypoxic cells located in close
proximity, which would not have metastasised otherwise. These
observations of spatial (entrainment) and temporal (long-term
changes) coupling provide a well-grounded experimental basis
towards the construction of spatiotemporal models of tumour
development, which will be essential to understand the metastatic
potential of a cell.
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RESULTS
Hypoxia induces invasion and metastasis in vivo
Hypoxic tumour signature is usually monitored by the levels of
hypoxia-inducible factor 1α or 2α (HIF-1α or HIF-2α) or by the
expression of their target genes (for example, carbonic anhydrase
IX (CA9)).15 While the correlation between a hypoxic signature and
poor clinical prognosis is accepted for several tumours, including
NB,6,16,17 the duration and levels of hypoxia responsible for this
association remain unknown. To investigate how hypoxia affects
the growth and aggressiveness of NB, we grew NB cells on the
CAM of the chick embryo. Fluorescently labelled SK-N-AS cells,
which are derived from a metastatic site (bone marrow), were
cultured under normoxia, hypoxia (3 days in 1% O2) or treated with
the hypoxia mimic dimethyloxaloylglycine (DMOG). They were
implanted on the CAM at E7 and their ability to form tumours and
to invade chick tissues was assessed. Cells grown in normoxia were
capable of tumourigenesis but not of metastatic invasion
(Figure 1a). Although the primary tumour morphology was
variable, all tumours were found to be heavily vascularised. Some
tumours also presented as haemorrhagic lesions or surrounded by
haematoma (Supplementary Figure S1A), a morphology commonly
present in NB.18 Interestingly, SK-N-AS cell preconditioning in 1%
O2 for 3 days led not only to tumourigenesis on the CAM but also
to clear metastasis in the chick embryo organs (Figure 1b).
Frequent sites of secondary tumour formation were the gut,
adjoining tissues (mesentery) and, crucially, the liver, which is a
common site for tumour metastasis in patients with NB.8,19 Other
less frequently invaded regions were the kidney and meninges
(gallery of images in Supplementary Figure S1B).
Hypoxia primarily triggers HIF stabilisation, due to a decrease of
the activity of the prolyl-hydroxylase domain enzymes. To
investigate if the hypoxia-driven metastasis was due to a decrease
in prolyl-hydroxylase domain activity, cells were treated for 1 day
with DMOG, a reversible prolyl-hydroxylase domain inhibitor
causing HIF-1/2α accumulation regardless of external oxygen
tension. Similar to hypoxia, DMOG treatment resulted in both
tumourigenesis and invasion (Figure 1c), indicating a likely role of
HIF in the induction of NB metastasis.
Primary tumour occurrence was similar among the conditions
(normoxia: 40%; hypoxia: 56%; DMOG: 58%); however, tumours
formed by cells precultured in hypoxia grew to a larger volume
than those of cells precultured in normoxia, with a mean of 76 and
13mm3, respectively (Figure 1d). More importantly, cells cultured
in normoxia did not show any metastatic potential (0%),
compared with 52% and 75% for preconditioned cells in 1% O2
or DMOG, respectively (Figure 1e). We further examined if hypoxic
preconditioning inﬂuenced cell proliferation (Figure 1f). Exposure
of NB cells to 1% O2 for 3 days had no effect on the number of
proliferative cells in vitro, with an average of 30% Ki-67-positive
cells in both conditions. In vivo, however, hypoxic preconditioning
caused an increase in proliferation on the CAM from 54 to 89%
positive cells, consistent with the larger tumour volume observed,
and 69% proliferation in metastasised cells (Figure 1g).
Ampliﬁcation of the proto-oncogene transcription factor MYCN
is found in about 25% of NB cases and correlates with high-risk
disease and poor prognosis.20 As SK-N-AS cells are non-MYCN-
ampliﬁed, the same experiments were repeated with the MYCN-
ampliﬁed SK-N-BE(2)C cell line. Similar results were obtained
(Supplementary Figures S1C–E), indicating that the impact of
hypoxia on NB metastasis is likely to be independent of the MYCN
ampliﬁcation.
Invasion by non-metastatic cells can be triggered by close contact
with metastatic cells
The pathological low oxygen tension found in most solid tumours
is described as heterogeneous and dynamic in space and time.10
It is therefore expected that a mixed population of hypoxic and
normoxic cells coexists as opposed to one homogenous cell
population. To reproduce a more pathophysiological situation,
and to assess if the presence of a small number of hypoxic cells
could inﬂuence normoxic non-metastatic cells, we implanted
mixed-cell populations. Cells were labelled with either enhanced
green ﬂuorescent protein (EGFP) or dTomato. To exclude the
possibility that tumour cell behaviour is inﬂuenced by the
ﬂuorescent protein used to label the cells, all experiments
conducted with EGFP-expressing cells (Figure 1) were reproduced
with dTomato-expressing cells leading to similar results
(Supplementary Figures S2A and B).
First, we implanted a mixed population of SK-N-AS-dTomato cells
precultured in normoxia and SK-N-AS-EGFP cells precultured for
3 days in 1% O2. Tumourigenesis took place as described previously.
Interestingly, metastasis occurred not only for cells precultured in
hypoxia but also for the normoxic ones (Figure 2a, metastasis in the
intestine and mesentery). We then investigated if a close but
indirect contact of hypoxic and non-hypoxic cells could impact on
their invasive ability. Hypoxic and normoxic preconditioned cells
were implanted on different locations on the CAM of the same chick
embryo. Again, tumourigenesis was observed for both cell types,
with the tumours being physically separated and no obvious cell
mixing (Figure 2b). In this case, the metastatic dissemination was
only detected for cells precultured in hypoxia (Figure 2b), indicating
that hypoxic preconditioning enables invasion of cells unable to
metastasise on their own; however, close proximity and direct cell–
cell contact are needed for such facilitation.
Hypoxia promotes active intravasation and slows down the
vascular migration
We then investigated which steps of the metastatic process were
enabled by hypoxic preconditioning. We ﬁrst assessed if hypoxic
preconditioning had an effect on how cells could migrate towards
blood vessels by staining CAM tumour samples with a marker of
the smooth muscle cells. Cells were detected at or within the
vasculature only for tumours formed by hypoxic preconditioned
cells (Figure 3a), indicating that hypoxia facilitates and potentially
even enables the intravasation of cells into the circulation.
To assess if hypoxia also inﬂuences margination (attachment to
the endothelial layer of the vasculature), we directly injected cells
intravenously at E3 (Figure 3b). Chick embryos were then imaged
live, ex ovo, for up to 30 h after injection. At 40min after injection,
some SK-N-AS cells had already settled in tissues, whereas
others were still circulating in the vasculature (Figure 3c and
Supplementary Video S1). To quantify cell migration within blood
vessels, a single-cell suspension of EGFP- (hypoxic preconditioning)
and dTomato-labelled SK-N-AS cells (normoxic preconditioning)
was coinjected and cell velocity in the blood vessels was measured
using fast ﬂuorescence imaging (Figure 3d and Supplementary
Video S2). Cells preconditioned in hypoxia moved, on average, at
half the speed of the cells preconditioned in normoxia (Figure 3e).
This will likely facilitate cell attachment to the vessel wall and
subsequently enable extravasation. Altogether, these data indicate
that, while hypoxia enhances cell migration from the primary
tumour towards blood vessels, it also clearly decreases the velocity
within the vasculature. In this respect, the changes in cell adhesion
properties triggered by hypoxia are likely to be multifaceted.
Hypoxic preculture increases invasion, microtumour formation
and is dependent of duration and level of hypoxia
We further sought to elucidate the long-term consequences of the
different vascular migration pattern, by monitoring the coinjected
cells over time, in ovo, up to E10. In the chick embryo, as well
as in its extraembryonic blood vessels, hypoxic preconditioned cells
formed aggregates, as early as 10min after injection, whereas cells
precultured in normoxia were rather found as single, isolated cells
(Figure 4a). The initial aggregates formed by hypoxic cells turned
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Figure 1. Preculture in 1% O2 for 3 days triggers metastasis in vivo. EGFP-labelled SK-N-AS cells were implanted on the CAM of E7 chick
embryos. Tumourigenesis on the CAM and metastasis inside the chick organs was monitored at E14. (a) Representative images of
tumourigenesis (upper panel) and invasive behaviour in the intestine (lower panel) are shown for cells grown under normoxia. Scale bar is
500 μm. (b) Same as in (a) with cells precultured for 3 days in 1% O2, before CAM implantation. (c) Same as in (a) with SK-N-AS cells pretreated
with DMOG (0.5 mM, 1 day). (d) Box plot depicting mean volume of tumours formed on the CAM at E14 by SK-N-AS cells precultured at 21%
(white, n= 11) or 1% O2 (grey, n= 12) for 3 days. (e) Quantitative analysis of metastatic tumour occurrence measured at E14. Displayed is the
percentage of embryos with metastasis observed in any site relative to tumour-bearing chicks. Bars represent the mean± s.e.m. from at least
16 embryos. **P⩽ 0.01 and ***P⩽ 0.001 compared with normoxia. (f) Ki-67 staining (red for in vitro and brown for in vivo) of SK-N-AS cells
cultured for 3 days at 21% O2 or 1% O2 cultured in vitro (nuclei (blue) staining with Hoechst 33342) or in vivo forming primary tumours on the
CAM or secondary tumours in chick embryos. Scale bar is 100 μm. (g) Quantiﬁcation of Ki-67-positive cells out of the total cell number. Bars
represent mean± s.e.m. from three independent experiments. ***P⩽ 0.001 compared with normoxia.
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into rounded microtumours within 24 h. To assess proliferation,
samples of coinjected cells were stained for Ki-67. At E10, the few
remaining cells from normoxic preculture failed to display any
positive staining, whereas 15% of the cells preexposed to hypoxia
were proliferative (Figure 4b). This is consistent with results
previously obtained in the CAM model (Figure 1g).
To elucidate the oxygen level and exposure time necessary to
induce the observed invasive phenotype, SK-N-AS-dTomato cells
cultured in normoxia were coinjected with SK-N-AS-EGFP cells
cultured in either 8% or 1% O2 for 3 days or 1 day, or pretreated
with DMOG as a comparison. Preconditioning at physiological
normoxia (8% O2 for 3 days) failed to induce microtumour
formation as well as a short-term exposure of 1 day in 1% O2
(Figure 4c). In contrast, DMOG-treated cells formed microtumours
(Figure 4d). In summary, hypoxic preconditioning needs to consist
of at least 3 days at 1% O2 to promote extravasation and tumour
formation in secondary sites.
Hypoxic preconditioning is sufﬁcient to activate long-lasting
transcription of several prometastatic genes
Although we observed profound phenotypic effects triggered by
preculture in a hypoxic environment, from the implantation/
injection time until the endpoint measurements up to 1 week
later, the cells were no longer in a controlled hypoxic environ-
ment. Thus, one question was: how long lasting are the effects of a
hypoxic preincubation upon reoxygenation? We measured
transcriptional outputs by quantitative PCR (qPCR), for a number
of genes involved in intravasation (for example, cell–cell adhesion;
matrix metalloproteases; epithelial–mesenchymal transition),
extravasation (for example, epithelial cell adhesion; glycoproteins)
and a classical hypoxic response (for example, vascular endothelial
growth factor (VEGF), glucose transporter type 1 (GLUT1)). For a
complete list of the 23 genes measured, their function and
heatmap response to hypoxia (see Supplementary Figure S3A).
Experimental conditions are detailed in Figure 5a. Figures 5b and
d show the relative gene expression of SK-N-AS cells in vitro,
cultured in hypoxic conditions with or without reoxygenation and
normalised to normoxic-untreated conditions.
Interestingly, while the classical hypoxic target genes were
sensitive to reoxygenation, with a signiﬁcant loss of expression of
GLUT1, CA9 and VEGF after 3 days of reoxygenation (Figure 5b),
for several genes involved in the intravasation process, the
reoxygenation ampliﬁed the regulatory effects initially triggered
by hypoxia. For example, for matrix metallopeptidase 9 (MMP9),
~ 15-fold upregulation was observed when hypoxia was followed
by reoxygenation compared with ~ 3-fold increase for hypoxia
only (Figure 5c). The response of genes involved in extravasation
was regulated by hypoxia and insensitive to reoxygenation
(Figure 5d). However, ITGB5 (integrin-β5), MMP2 and NCAM (neural
cell adhesion molecule) were sensitive to reoxygenation, akin to
the classical hypoxic target genes. Nevertheless, these results
show that a signiﬁcant number of metastatic genes regulated by
hypoxic preconditioning were still up- or downregulated 3 days
after reoxygenation and could explain the invasive phenotype
observed in vivo.
We next measured how the expression of the same genes was
regulated in cells forming tumours in vivo. Figure 5e, f and g show
that 21 out of the 23 genes measured were signiﬁcantly regulated
in the tumours formed by hypoxic or DMOG-treated cells
compared with tumours formed by normoxic cells. In comparison,
only 13 genes were signiﬁcantly regulated in cells maintained
in vitro. Importantly, for several genes, the effects of hypoxia
were much stronger. For example, MMP9 was upregulated more
than 50 times in hypoxic tumours compared with the normoxic
tumours, but was only increased 3.5 times by hypoxia in vitro.
This enhancement of gene expression regulation in vivo was
observed for all genes measured regardless of their up- or
Figure 2. Invasion of normoxic cells can be initiated by direct interaction with hypoxic cells. EGFP- and dTomato-labelled SK-N-AS cells were
implanted on the CAM of E7 chick embryos. SK-N-AS-dTomato cells were precultured at 21% O2 for 3 days and SK-N-AS-EGFP cells were
precultured at 1% O2 for 3 days. (a) SK-N-AS-EGFP and SK-N-AS-dTomato cells were mixed before CAM implantation. Pictures show
tumourigenesis on the CAM (upper panel) and invasive behaviour in the intestine (lower panel) at E14. Scale bar is 500 μm. (b) SK-N-AS-EGFP
and SK-N-AS-dTomato cells were implanted separately on different locations on the CAM. Pictures show tumourigenesis on the CAM at E14
and intestinal metastasis by the SK-N-AS-EGFP. Scale bar is 500 μm.
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downregulation proﬁle. These observations reinforce the concern
that cells in culture behave differently from cells in a more
physiological and 3D environment and that some molecular
changes might be missed in in vitro cultures, where extracellular
matrix components and tight cell–cell junctions are absent.
Taken together, these results demonstrate that hypoxic
preexposure induces a strong regulation of many genes involved
in metastasis even 7 days later. The hypoxic memory effect
observed in in vivo tumours was also observed at the protein level.
For example, CA9 staining was markedly pronounced in tumours
formed by cells precultured in hypoxia (Supplementary Figure
S3B). Surprisingly, staining for HIF-1α and HIF-2α in tumours
did not vary between normoxic and hypoxic preincubation
(Supplementary Figure S3B), indicating that HIF-1/2α levels might
not be the most adequate markers to detect previous hypoxic
episodes experienced by tumour cells. The low HIF-2α levels were
in agreement with a previous report where SK-N-AS cells, and
other NB cell lines, failed to display detectable HIF-2α expression
regardless of oxygen tension.17
HIF activity is required for the acquisition of the metastatic
phenotype
Given the results obtained with DMOG, we aimed to probe the
role of HIF activity in the metastatic phenotype and gene
expression regulation. We used both a genetic and pharmacolo-
gical approach to inhibit HIF-dependent transcription. An HIF-1β
knockdown strategy was used to test a global HIF-1α/HIF-2α
contribution, by blocking both HIF-1α/HIF-1β and HIF-2α/HIF-1β
heterodimer formation needed for gene transcription regulation.21
HIF-1β expression was reduced by ~ 50% in shHIF-1β cells
(Figure 6a). Alternatively, we used digoxin, a cardiac glycoside
reported to inhibit translation of HIF-1α and HIF-2α mRNA.22
Digoxin treatment with 5, 10 or 100 nM resulted in a reduction of
HIF-1α expression by 50%, 72% or 82%, respectively (Figure 6b).
Digoxin also decreased cell survival by about 70% (Figure 6c).
We selected 10 nM digoxin, which was sufﬁcient to reduce HIF-1α
levels by 72% in SK-N-AS cells exposed to 1% O2 while
maintaining a survival of about 30% in normoxia and hypoxia.
Figure 3. Hypoxia promotes active intravasation and slows vascular migration. (a) Representative pictures of CAM tumour sections from
tumours formed at E14 by SK-N-AS-EGFP cells precultured in 21% O2 (upper panel) or 1% O2 (lower panel) for 3 days. SK-N-AS cell (green)
proximity to the blood vessels (smooth muscle actin staining, red) is observed for hypoxic but not normoxic preconditioned cells. Nuclei are
stained with Hoechst 33342 (blue). Scale bar is 100 μm. (b) Representative image of a chick embryo at E3, with its extraembryonic blood
vessels. The arrow indicates the site of intravenous injection. Scale bar is 500 μm. (c) Typical image from live ex ovo imaging 40min after
injection of SK-N-AS-EGFP cells in an E3 chick embryo. The eye of the embryo is outlined. The arrows point to some EGFP-labelled SK-N-AS
cells settled in the embryo. Scale bar is 20 μm. (d) SK-N-AS-EGFP (precultured in 1% O2, 3 days) and dTomato cells (precultured in 21% O2,
3 days) were coinjected in the blood vessels of an E3 chick embryo as shown in (c). The picture was taken 10min after injection by live ex ovo
imaging. Image capture time is 500ms and scale bar is 100 μm. (e) Velocity of coinjected SK-N-AS cells precultured at 21% O2 or 1% O2 was
calculated as indicated in Materials and methods. Approximately 150 cells for each condition acquired from six embryos were quantiﬁed. The
plot represents the ratio of velocity for each individual EGFP cells divided by the average velocity of the dTomato cells. The mean ratio 0.66 is
statistically different from 1 with P⩽ 0.001. The absolute mean velocity was measured as 1600 μm/s for cells preconditioned in hypoxia and
3200 μm/s for normoxic cells.
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Figure 4. Hypoxia-induced microtumour formation is dependent on the duration and level of oxygen preconditioning. (a) SK-N-AS-dTomato
(precultured in 21% O2, 3 days) and SK-N-AS-EGFP cells (precultured in 1% O2, 3 days) were coinjected intravenously in E3 chick embryos.
Microtumour formation was followed over time. The pictures show SK-N-AS cells in the chick embryo (upper panel) or its extraembryonic
blood vessels (lower panel), 10 min, 3 h, 24 h and 4 days after intravenous coinjection. Scale bar is 200 μm for 10 min, 3 h, 24 h and 50 μm for
4-day images. (b) Quantiﬁcation of Ki-67-positive cells relative to total cell number in metastatic sites, and 7 days after intravenous injection.
Bars represent mean± s.e.m. from three independent experiments. ***P⩽ 0.001 compared with normoxia. (c) Microtumour formation does not
occur in mild hypoxia (8% O2) or a shorter exposure to 1% O2. SK-N-AS-dTomato (precultured in 21% O2, 3 days) were coinjected with SK-N-
AS-EGFP preconditioned for 3 days in 8% O2 (upper panel) or for 1 day in 1% O2 (lower panel). Images show SK-N-AS cells in the
extraembryonic blood vessels, 10 min, 3 h, 24 h and 4 days after intravenous injection. Scale bar is 200 μm. (d) SK-N-AS-EGFP (pretreated with
0.5 mM DMOG for 1 day) and dTomato cells (precultured in 21% O2, 1 day) were coinjected intravenously in E3 chick embryos. DMOG
treatment results in microtumour formation over time. The pictures show SK-N-AS cells in the chick embryo (upper panel) or its
extraembryonic blood vessels (lower panel), 10 min, 3 h, 24 h and 4 days after intravenous coinjection. Scale bar is 200 μm.
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Figure 5. Hypoxic exposure triggers long-lasting changes in the expression of genes involved in invasion, intravasation, adhesion and
extravasation. (a) Schematic representation of the experimental protocol. Arrows indicate when samples were collected for qPCR analysis.
Relative mRNA levels of genes related to hypoxia and poor prognosis (b and e), invasion and intravasation (c and f) and adhesion and
extravasation (d and g) were measured by qPCR in cells cultured in vitro (b–d) and in cells forming tumours (e–g). (b–d) SK-N-AS cells were
cultured for 3 days in 21% O2 (control for normalisation), 1% O2 (grey bar), 3 days in 1% O2, followed by 3 days in 21% O2 (dark grey bar) or
treated for 1 day with DMOG (black bar). mRNA levels were measured relative to cyclophilin A and normalised to relative levels of cells
precultured at 21% O2. (e–g) Cells were precultured for 3 days in 21% O2 (control for normalisation), 1% O2 (grey bar) or treated for 1 day with
DMOG (black bar) before implantation on the CAM at E7. At least six tumours were collected at E14 for each condition and relative mRNA levels
are displayed relative to cyclophilin A and normalised to tumours formed with cells precultured for 3 days at 21%. Bars represent the logarithm
of the normalised mean± s.e.m. of at least three independent experiments. *P⩽ 0.05, **P⩽ 0.01 and ***P⩽ 0.001 compared with normoxia.
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Normoxic preculture of shHIF-1β-SK-N-AS- or digoxin-treated
SK-N-AS cells resulted in tumourigenesis only for shHIF-1β cells (in
50% of chick embryos, similarly to WT cells) (Figure 6d). Tumours
derived from shHIF-1β cells displayed deregulated vasculature and
an almost complete lack of blood vessels. When cells were
preconditioned in hypoxia, tumour formation was observed in
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both cell types (46% for shHIF-1β cells and 40% for digoxin-
treated cells; Figure 6e). However, no metastasis was observed in
either condition, suggesting the necessity of an active HIF module
for the initiation of metastasis. At the transcriptional level of a
selected subset of genes, shHIF-1β cells still showed an induction
of HIF-1α target genes in hypoxia, in vitro (Figure 6f). On the
contrary, in vivo, none of the HIF target genes nor classical
metastatic genes were induced (Figure 6g), consistent with the
avascular phenotype of the tumours. Digoxin blocked HIF-
dependent transcription both in vitro and in vivo (Figures 6f and
g). The induced transcription of HIF target genes in case of HIF-1β
knockdown could be due to the remaining HIF-1β or compensa-
tion by HIF-2β subunits as has been reported for other NB cells.23
When mRNA levels measured in shHIF-1β or digoxin-treated cells
were normalised to their counterpart WT untreated cells (Figures
6h and i), all genes promoting metastatic dissemination were
signiﬁcantly reduced both in vitro and in tumours, in line with the
absence of invasion. These genes could therefore be used as
markers to predict the cell’s ability to metastasise. In summary,
functional HIF transcriptional activity is essential for the metastatic
phenotype of NB cells.
DISCUSSION
Monitoring metastasis over time in vivo
The chick embryo model has proven to be a powerful tool, which
can be readily imaged over time and in which the metastatic
potential of NB cells and other cancer cells (for example,
glioblastoma—unpublished observations) can be manipulated
by a hypoxic preconditioning. This model is also compliant with
the reduction of animal laboratory testing. Furthermore, it is
particularly well adapted for NB, a tumour originating from neural
crest cells during embryonic development, by mimicking its
pathophysiological conditions.24 This was conﬁrmed by the fact
that the tumourigenesis observed (Figure 1 and Supplementary
Figure S1) was similar to the clinical phenotype, including
haemorrhagic tumours18 and metastasis in similar organs.8,19
Tumourigenesis occurred frequently for both MYCN-ampliﬁed and
-non-ampliﬁed NB cell lines, whereas spontaneous metastasis only
occurred for cells precultured in hypoxia. Although our ﬁndings of
tumourigenesis of SK-N-AS cells are in agreement with previous
observations,25 the same group described spontaneous lung
metastasis of SK-N-AS cells detected by qPCR of the human Alu
sequence. No direct evidence of tumour growth in a given tissue
was provided, thus it is possible that their ﬁndings originated from
non-viable cell traces or artefacts. Here, ﬂuorescent cell labelling
enabled us to quickly and precisely visualise the location and
incidence of metastasis.
The impact of HIF-dependent transcription on cell survival and cell
adhesion properties
We showed that hypoxic preconditioning strongly reduced CASP8
and DCC expression, especially in vivo, potentially contributing to
the aggressive phenotype. CASP8 and DCC have been associated
with increased aggressiveness and poor prognosis in several
cancers including NB,25–28 and in NB lack of CASP8 has been
found to promote metastasis.29
The increased occurrence of hypoxic preconditioned cells in
proximity to blood vessels (Figure 3) indicates low binding
properties to the primary tumour and epithelial–mesenchymal
transition. This is supported by the regulation of MMP2 and 9,
TWIST1, SNAI1 and 2, CDH1, and so on. Conversely, hypoxia
resulted in a twofold decrease of velocity within the blood vessels,
likely increasing their attachment to the endothelial vessel wall
and extravasation. This can be explained by the hypoxic
regulation of members of the Ig-CAM superfamily such as VCAM,
ICAM and NCAM, as well as integrins (Figure 5), which all facilitate
ﬁrm adhesion and transmigration. This complexity and difference
in adhesion and migration pattern observed in vivo can explain
the contradictory ﬁndings previously reported in in vitro studies
using wound healing assays,30–33 which provide poor representa-
tion of the multifaceted migration found in three-dimensional
environments or in vivo.
The gene expression was long lasting, as shown by our qPCR
experiments, with many genes showing very stable expression
even after a relatively long reoxygenation period (Figure 5). This
could be explained by the fact that a chronic hypoxic exposure
allows long-lasting epigenetic remodelling,34 underlying the
striking memory of the preexposure to hypoxia.
The observed changes in gene expression upon hypoxic
exposure might not all be due to a direct HIF regulation, yet
most of them have previously been shown to be regulated by
either HIF-1α and/or HIF-2α. Surprisingly, we found that hypoxic
preconditioning had no inﬂuence on HIF protein levels in the
tumours (Supplementary Figure S3B), suggesting that HIF target
gene expression rather than HIF levels is likely to provide more
reliable markers to monitor tumour hypoxia or hypoxic episodes.
Spatial and temporal features of hypoxic regions mediate
metastatic progression
Malignant tumours experience a highly dynamic range of oxygen
gradients,10 which is likely to impact on the spatial heterogeneity
of tumours, forming a mixed population of normoxic and hypoxic
cells. Remarkably, we observed that invasion by non-metastatic
normoxic cells could be triggered by direct contact with hypoxic
preconditioned cells (Figure 2). We propose the possible and non-
exclusive following mechanisms: (1) hypoxic preconditioned cells
Figure 6. HIF inhibition prevents hypoxia-induced metastasis. (a) Validation of HIF-1β knockdown by western blot. SK-N-AS-EGFP cells were
stably transduced with shHIF-1β lentivirus. The knockdown efﬁciency was assessed in normoxia and hypoxia (1% O2, 6 h). Sample loading was
normalised with anti-β-actin staining. (b) SK-N-AS cells were treated with indicated concentrations of digoxin. The effect of digoxin on HIF-1α
protein levels was assessed in normoxia or hypoxia (1% O2, 6 h). Sample loading was normalised with anti-β-actin staining. (c) Survival of SK-N-
AS cells upon digoxin treatment. SK-N-AS cells were treated with indicated concentrations of digoxin and subsequently cultured under
normoxia or hypoxia for 3 days. Cell viability was measured by MTS assay and is displayed relative to the control (DMSO-treated cells). (d) SK-
N-AS-EGFP cells transduced with HIF-1β (upper panel) or SK-N-AS-EGFP treated with 10 nM digoxin for 3 days (lower panel) were implanted on
the CAM of E7 chick embryos. Tumourigenesis on the CAM was assessed at E14 in at least 15 embryos. Representative images are shown.
Scale bar is 500 μm. (e) Same as in (d) but cells were precultured in 1% O2 for 3 days. No metastasis could be detected in any of the embryos
where primary tumours were found. Scale bar is 500 μm. (f) shHIF-1β SK-N-AS-EGFP or SK-N-AS-EGFP treated with 10 nM digoxin for 24 h were
cultured for 3 days in 21% O2 or 1% O2 in vitro. mRNA levels relative to cyclophilin A were measured by qPCR. Bar graph represents the
mean± s.e.m. of at least three independent experiments. *P⩽ 0.05, **P⩽ 0.01 and ***P⩽ 0.001 compared with normoxia. (g) The same cells
and culture conditions as in (f) were used and implanted onto the CAM at E7. Three tumours from shHIF-1β cells and two from digoxin-treated
cells were collected at E14 and mRNA levels relative to cyclophilin A were measured by qPCR. Bar graph represents the mean± s.e.m. (h and i)
Same samples and results as in (f and g) but normalised to non-treated WT 21 and 1% cells, to demonstrate the difference in metastatic gene
expression compared with WT cells (shown in Figure 5). Bar graph represents the logarithm of the normalised mean± s.e.m. of at least two
independent experiments. #P⩽ 0.05, ##P⩽ 0.01 and ###P⩽ 0.001 compared with WT cells cultured in 21% O2 and *P⩽ 0.05, **P⩽ 0.01 and
***P⩽ 0.001 compared with WT cells cultured in 1% O2.
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prepare an invasive path by promoting matrix degradation or
collective cell migration,35 which is supported by the fact that
normoxic cells were only found in organs invaded by hypoxic
cells. (2) Hypoxic and normoxic preconditioned cells could
communicate via the transfer of microvesicles potentially contain-
ing mRNA, DNA or lipids.36–38 Indeed, several reports document
that cancer cells under stress, such as hypoxia, shed vesicles,38,39
which have been shown to inﬂuence their microenvironment-
promoting metastasis.36,38
In conclusion, we have here demonstrated that some hypoxic-
induced phenotypes (including increased proliferation, target
gene expression and migration properties) were missed in the
in vitro culture system, which could have led to major
misinterpretation if not combined with in vivo studies. Our results
exemplify the importance of taking into account the spatial and
temporal heterogeneity found in solid tumours and crucially
demonstrate that the cells’ 'history' within the tumour is of prime
importance in understanding their phenotype. These ﬁndings
could have major therapeutic implications in the development of
cancer agents targeting hypoxic cells, and clearly highlight the




The human NB lines SK-N-AS and SK-N-BE(2)C (ECACC Nos 94092302 and
95011817) were grown in minimal essential medium supplemented with
10% foetal calf serum and 1% non-essential amino acids (both Life
Technologies, Carlsbad, CA, USA) and maintained in a humidiﬁed incubator
at 37 °C with 5% CO2. For hypoxic studies, cells were maintained at 37 °C with
5% CO2 and 1% O2 (Don Whitley Scientiﬁc, Shipley, UK; Hypoxystation-H35)
or 8% (Eppendorf, Hamburg, Germany; Galaxy 48 R). For DMOG treatment,
cells were cultured in media supplemented with 0.5mM DMOG (Enzo
Laboratories, Farmingdale, NY, USA) for 24 h. For digoxin treatment, 5, 10 or
100 nM digoxin (Sigma-Aldrich, St Louis, MO, USA) were added to the cells on
day 0 followed by incubation as indicated.
Stable cell line generation
Lentiviral particles were produced with the transfer vectors pHIV-dTomato
(Addgene, Cambridge, MA, USA; plasmid 21374), pLNT-SFFV-EGFP24 and
shHIF-1β (MISSION shRNA Plasmid DNA; Sigma-Aldrich) as described
previously.40 Transduction efﬁciency of ﬂuorescent cell lines was quantiﬁed
by ﬂow cytometry using a FACSCalibur Cytometer (BD Biosciences, Franklin
Lakes, NJ, USA), while shHIF-1β cells were selected using puromycin (Gibco,
Life Technologies).
Survival assay
Cell survival assays were performed using CellTiter 96 AQueous One
Solution Cell Proliferation Assay (MTS; Promega, Madison, WI, USA). To test
for digoxin-induced cytotoxicity, 5 × 104 cells per well were seeded in a 96-
well plate, treated as indicated and analysed 3 days later according to the
manufacturer’s instruction.
Immunocytochemistry and immunohistochemistry
For immunocytochemistry, cells were washed in phosphate-buffered
saline and ﬁxed in 4% formaldehyde (Sigma-Aldrich) for 10min.
Immunocytochemistry was performed using standard protocols.
For immunohistochemistry (IHC), tissue samples were ﬁxed for up to
12 h in 10% formalin (Sigma-Aldrich) or 4% formaldehyde for the
preparation of parafﬁn or frozen sections, respectively. IHC of 4-μm-thick
parafﬁn sections or 10-μm-thick frozen sections was performed using
standard protocols.
Cell nuclei were stained with TO-PRO-3 (Life Technologies) and the
following primary antibodies were used: mouse anti-Ki-67 (immunocyto-
chemistry and IHC 1:100), mouse anti-CD56 (IHC-P 1:50; both Leica
Novacastra, Wetzlar, Germany), rabbit anti-smooth muscle actin α (IHC-F
1:200), rabbit anti-MMP9 (IHC-P 1:100), rabbit anti-CA9 (IHC-P 1:1000; all
Abcam, Cambridge, MA, USA), mouse anti-HIF-1α (IHC-P 1:100; NovusBio,
Littleton, CO, USA) and rabbit anti-HIF-2α (IHC-P 1:1000; BD Biosciences).
Antibodies used for IHC-P were validated and optimised in tissues known
to show a positive reaction according to the human protein atlas (http://
www.proteinatlas.org/). Cells were analysed by confocal microscopy (Zeiss,
Oberkochen, Germany; lsm710) and images were acquired using the
ZEN2012 software. Image analysis and cell quantiﬁcation were performed
with ImageJ (WS Rasband, ImageJ, U. S. National Institutes of Health,
Bethesda, MD, USA). For quantiﬁcation, a total of 500 to 1500 positive cells
per slide and at least ﬁve slides were counted per experiment and
condition.
Quantitative PCR
For cells in culture qPCR was performed as described previously.41 A list of
all primers used is provided in Supplementary Table S1.
For primary tissues, tumours harvested from the CAM were rinsed in ice-
cold phosphate-buffered saline, transferred into RNAlater solution
(Ambion, Life Technologies), isolated with NucleoSpin RNA Tissue Kit
(Macherey-Nagel, Dueren, Germany) according to manufacturer’s instruc-
tions and processed using the same methods described for cells.
Western blot
Immunoblotting was performed as described previously41 with primary
antibodies against HIF-1α (1:1000; BD Biosciences), HIF-1β (1:500; Novus
Bio) or β-actin (1:1000; Abcam).
Chick embryos
Intravenous injection and ex vivo imaging. Intravenous injection at E3 was
performed as described previously.24 For coinjection, NB cells cultured
under different conditions were mixed before injection. Cells were either
imaged in ovo and followed until E10 using a standard ﬂuorescent stereo
microscope (Leica M165-FC) before dissection or the embryo
was transferred onto a 3.5 mm glass bottom dish (Greiner, Bio-One,
Frickenhausen, Germany) immediately after injection and imaged for up to
30 h at 37 °C with an epiﬂuorescent microscope (Axio ObserverZ1; Zeiss)
equipped with a fast acquisition CMOS camera (Andor, Belfast, UK). Videos
were taken with a x10 objective and 500 frames at 29 frames per s were
acquired. Quantiﬁcation of cells in the circulation was performed on six
different embryos from four independent experiments. Blood vessels close
to the heart with a pulsatile rhythmic ﬂow were not taken into
consideration to avoid artefacts in the velocity calculation. About 150
cells were analysed for each condition. Velocity was calculated by
converting the number of frames necessary for a cell to cross the ﬁeld
of view to μm/s.
CAM assay. For CAM implantation at E7, ﬂuorescent NB cells were
harvested as above and 1× 106 cells per μl were resuspended in serum-
free media. CAM implantation was achieved by transferring 2 μl of the cell
suspension into the membrane fold created by careful laceration. For
coimplantation, NB cells cultured under different conditions were mixed
before implantation. After CAM implantation, eggs were incubated until
E14 and imaged using a standard ﬂuorescent stereo microscope (Leica
M165-FC). Tumours grown upon the CAM were imaged from three
different perspectives (dorsal, ventral and lateral) demonstrating the depth
of tumour growth. Average tumour volume was calculated using V= (4/3)
π× length× height × depth of at least three different tumours and
repeated in at least four independent experiments. Following removal of
primary tumours from the CAM, embryos were dissected. Organs were
removed and tumour cells and/or metastatic deposits identiﬁed by
ﬂuorescence.
Statistical analysis
Statistical signiﬁcance was computed using Student’s t-test using Origin-
Pro 8.6 (OriginLab Corporation, Northampton, MA, USA).
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